MOL

Meghmani Organics Share Price

 

Stock Result Declared

 

Invest in Meghmani Organics with 3.01X leverage

Invest with MTF

Performance

  • Low
  • ₹74
  • High
  • ₹77
  • 52 Week Low
  • ₹56
  • 52 Week High
  • ₹108
  • Open Price₹76
  • Previous Close₹76
  • Volume1,027,312

Investment Returns

  • Over 1 Month -9.45%
  • Over 3 Month -13.14%
  • Over 6 Month + 8.4%
  • Over 1 Year -26.83%

Smart Investing Starts Here Start SIP with Meghmani Organics for Steady Growth!

Invest Now

Meghmani Organics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 47.8
  • PEG Ratio
  • 0.3
  • Market Cap Cr
  • 1,896
  • P/B Ratio
  • 1.3
  • Average True Range
  • 2.25
  • EPS
  • 0.74
  • Dividend Yield
  • 0
  • MACD Signal
  • -1.02
  • RSI
  • 28.55
  • MFI
  • 30.12

Meghmani Organics Financials

Meghmani Organics Technicals

EMA & SMA

Current Price
₹74.57
-1.06 (-1.4%)
pointer
  • Bearish Moving Average 16
  • Bullish Moving Average 0
  • 20 Day
  • ₹79.75
  • 50 Day
  • ₹82.13
  • 100 Day
  • ₹83.64
  • 200 Day
  • ₹84.12

Resistance and Support

75.4 Pivot Speed
  • R3 79.70
  • R2 78.54
  • R1 76.56
  • S1 73.42
  • S2 72.26
  • S3 70.28

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Meghmani Organics Ltd. is a leading manufacturer of specialty chemicals and agrochemicals in India. The company specializes in producing dyes, pigments, and herbicides, focusing on quality and sustainability to serve various industries, including textiles, agriculture, and pharmaceuticals.

Meghmani Organics has an operating revenue of Rs. 2,279.49 Cr. on a trailing 12-month basis. An annual revenue growth of 32% is outstanding, Pre-tax margin of 0% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 19%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 65 which is a FAIR score but needs to improve its earnings, a RS Rating of 36 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 127 indicates it belongs to a poor industry group of Chemicals-Agricultural and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Meghmani Organics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-08 Quarterly Results
2025-07-30 Quarterly Results
2025-05-10 Audited Results
2025-02-08 Quarterly Results
2024-10-26 Quarterly Results
Date Purpose Remarks
2023-06-20 FINAL Rs.1.40 per share(140%)Final Dividend
2022-06-20 FINAL Rs.1.40 per share(140%)Final Dividend
View Meghmani Organics Dividend History Arrow

Meghmani Organics F&O

Meghmani Organics Shareholding Pattern

48.98%
0%
1.48%
39.19%
10.35%

About Meghmani Organics

  • NSE Symbol
  • MOL
  • BSE Symbol
  • 543331
  • Chairman & Managing Director
  • Mr. Ankit Patel
  • ISIN
  • INE0CT101020

Similar Stocks to Meghmani Organics

Meghmani Organics FAQs

Meghmani Organics share price is ₹74 As on 09 November, 2025 | 14:45

The Market Cap of Meghmani Organics is ₹1896.4 Cr As on 09 November, 2025 | 14:45

The P/E ratio of Meghmani Organics is 47.8 As on 09 November, 2025 | 14:45

The PB ratio of Meghmani Organics is 1.3 As on 09 November, 2025 | 14:45

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23